top of page


dOPAMINE deficiency
Dopamine is best known as the brain’s reward chemical, driving sensations of pleasure and satisfaction. Yet beyond this familiar role, dopamine is a remarkably versatile neurotransmitter that exerts wide-ranging effects throughout both the brain and body
Surprisingly, up to 46% of the body's total dopamine is produced outside the brain, primarily within the gastrointestinal (GI) tract and other organs like the spleen and pancreas [1].
In the GI tract, dopamine functions as a key neuromodulator, binding to dopamine receptors on the smooth muscle and playing an integral role in regulating gut motility, fluid secretions, and mucosal blood flow [2].
Although dopamine that is produced in the gut cannot cross the blood–brain barrier, the gut microbiota play a pivotal role in synthesizing the dopamine precursor, L-DOPA. It is L-DOPA that enters the systemic circulation and crosses into the brain to support local dopamine synthesis. Therefore, gut production impacts the brain support [3].
The remaining dopamine is produced locally within the brain, by specific dopaminergic neurons. This dopamine is then taken up by dopamine active transport proteins (DAT) to be transported throughout the brain. Transportation is a key component of supporting the various dopaminergic effects. This is because there are five distinct types of receptors for dopamine throughout the brain, and each has a unique role and effect.
Think of dopamine receptors as control switches, some such as D1 and D5 excite brain cells, while others, like D2, D3 and D4 calm brain cells down. Together, these switches create a carefully balanced system. If stimulation becomes unbalanced due to one group of receptors becoming overactive while others are underactive, the brain's functions can become dysregulated.
As an example, too much stimulation of D1 and D5 receptors can lead to overactivity, repetitive and impulsive behaviors, whereas too much inhibition via D2, D3 and D4 receptors might lead to slowed thinking, low motivation, or even coordination imbalances [4,5].
It is for this reason we ensure dopamine transportation is a key focus alongside dopamine production. Together this supports dopamine’s broad and multifaceted influence on brain function, which impacts a multitude of cognitive, behavioural and physiological effects, as detailed below.
Cognitive Processing
Dopamine is essential for high-level executive functions, particularly in the prefrontal cortex, where it regulates the neural circuits responsible for working memory, goal planning, selective attention, inhibitory control, and cognitive flexibility, including the ability to adapt strategies in response to changing environments or feedback. Optimal dopamine levels also promote efficient signal-to-noise ratio in the brain, helping filter out irrelevant information and supporting clear, goal-directed thought processes.
Learning & Memory
Dopamine facilitates synaptic plasticity, which is the brain’s ability to strengthen or weaken connections between neurons, which is the foundation of learning. It especially promotes long-term potentiation (LTP), a cellular mechanism crucial for memory encoding, consolidating short-term memories into long-term storage.
Positive Emotions & Reward
Dopamine is central to the brain’s reward circuitry, particularly within the mesolimbic pathway. This system underlies the experience of pleasure, happiness, and reward, and reinforces behaviors that lead to those outcomes. Dopamine release during rewarding experiences not only causes a feeling of enjoyment but also strengthens the motivation to repeat the behavior, which is crucial for sustaining effort toward goals.
Stress & Adaptation
Dopamine helps the brain process emotional stimuli and adapt to environmental changes. It modulates how stress is perceived and handled, supporting emotional regulation and resilience. In the face of stress dopamine promotes greater behavioral flexibility, better emotional control, and lower vulnerability to chronic stress.
Motor Control & Coordination
Dopamine regulates voluntary movement by acting on pathways within the basal ganglia. It ensures smooth, precise, and vigorous motor output by coordinating muscle groups and suppressing involuntary movements.
[6,7,8,9]
It is evident that optimal dopamine levels are crucial for maintaining mental, emotional, and physiological well-being. Therefore, when this system becomes impaired, whether through limited synthesis, accelerated breakdown, poor reuptake, or dysfunctional receptor activity, the resulting deficiency in dopaminergic signaling leads to a cascade of negative effects commonly referred to as low dopamine.
signs & symptoms
Attention-Deficit Hyperactivity Disorder (ADHD)
ADHD is categories by the following
-
Inattention - difficulty paying attention, keeping on task, or staying organized
-
Executive dysfunction - challenges with starting, sequencing, and completing tasks.
-
Hyperactivity - often moving around, feeling restless, or talking excessively
-
Working memory deficits - forgetting instructions, misplacing items, or failing to recall steps
When ADHD is treated pharmaceutically, commonly used medications work as dopamine reuptake inhibitors (NDRI), which increases the utilisation of dopamine within the brain. They also simultaneously act by inducing expression of the dopamine transporters (DAT), which improves dopamine exposure throughout different regions of the brain [10].
The multiaction of both increasing and delivering dopamine is fundamental to alleviating ADHD symptoms. This has been demonstrated in brain scans using PET imaging on individuals with ADHD. The results indicated some brain areas showed lower dopamine, while others showed higher dopamine [11,12].
This demonstrates potential dopamine deficiency as one component, but it rides equally alongside ensuring dopamine transport to all necessary regions and receptors of the brain. This thereby supports dopaminergic effects whilst balancing the response.
Scattered Mind
Evidence has shown that low dopamine release in the dorsolateral prefrontal cortex contributes to disorganized or "scattered" thinking. This is because the dorsolateral prefrontal cortex DLPFC is central to organizing thoughts, maintaining goal-directed behavior, and filtering out irrelevant information [13,14]
Low dopamine in this region impairs the brain’s ability to maintain and manipulate information, leading to:
-
Disorganized thinking
-
Reduced focus or attentional control
-
Difficulty maintaining and revising information in the mind
-
Trouble staying on topic
Impaired Memory
Dopamine D1 activity increases brain activity in memory-related areas like the Hippocampus, Amygdala and Substantia nigra/ventral tegmental area (SN/VTA), and has been clinically shown to support not only memory formation, but memory retrieval.
Studies demonstrate that low dopamine has a mild association with significantly reduced memory, but when coupled with low acetylcholine has a much more significant effect. Therefore poor memory should be treated simultaneously with dopamine support and choline supplementation [15,16].
Anhedonia - Loss of pleasure
Anhedonia refers to the loss of pleasure from experiences that would ordinarily feel rewarding. Under normal conditions, dopamine neurons in the ventral tegmental area (VTA) fire in bursts when exposed to pleasurable cues, releasing dopamine into regions such as the nucleus accumbens and prefrontal cortex. When dopamine activity is reduced, fewer neurons fire spontaneously and dopamine release is blunted, meaning that otherwise enjoyable activities fail to produce the usual sense of pleasure.
Diminished Drive to Pursue Rewards
Under normal conditions, dopamine neurons in the ventral tegmental area (VTA) generate both a tonic baseline signal and phasic bursts in response to rewarding or motivationally significant cues. This is how dopamine enables a sense of an ‘anticipated reward value’, which is the degree of pleasure that will be experienced in the future for the effort of work that is required to be put in, in the present moment. Therefore, when dopamine is deficient the sense of ‘future reward’ becomes lost, and therefore so does its motivational pull.
In this state, people are less likely to engage in tasks that require sustained effort or patience, even if the long-term benefit is higher, because the brain under low dopamine conditions undervalues delayed outcomes. Instead, decision making becomes more orientated around instant gratification even though the scale of reward is less [27][28]
Personality Traits
-
Cautious - Avoiding High Risk
-
Prioritising Safety and Stability
-
Predictable
-
Slow Tempered
-
Averse to high-energy pursuits
When dopamine signaling is low, personality expression often moves towards traits described as cautious, reliable, slow-tempered, with a marked absence of impulsiveness or curiosity for newness. This is because dopamine plays a central role in driving exploratory behavior, evaluating potential rewards, and fueling motivation for new experiences. Without adequate dopamine, individuals become less responsive to reward cues, and their willingness to take risks or engage in novelty-seeking declines.
The result is a personality style characterized by risk aversion, where choices are made conservatively and with heightened focus on avoiding potential loss rather than pursuing potential gain. Novelty and sensation seeking, usually linked to dopamine-driven reward circuits in the striatum and prefrontal cortex, become diminished, leaving individuals less inclined to explore, experiment, or pursue new opportunities. Similarly, the drive to pursue rewards is weakened, as the motivational "pull" that dopamine normally provides is blunted. This creates a profile where behavior is more predictable, prioritizing safety, stability, and reliability over exploration of high-energy pursuits. [74]
Elevated Prolactin + Progesterone Deficiency
-
Premenstrual Syndrome (PMS)
-
Polycystic Ovaries or PCOS
-
Oligomenorrhoea - Irregular or extended cycle lengths
-
Amenorrhoea - Loss of Menstrual Cycle
-
Anovulation - Infertility
Dopamine from hypothalamic neurons reaches the anterior pituitary, and tonically binds to lactotroph cells in order to suppress prolactin synthesis and secretion. This action of dopamine serves as the principal day-to-day inhibition of prolactin output, and therefore prolactin balance relies heavily on dopamine availability. In clinical trials it has been demonstrated that a low-dose dopamine infusion significantly reduced serum prolactin levels, by approximately 79% within six hours. [18].
In cases of dopamine deficiency, elevated prolactin then suppresses hypothalamic GnRH secretion, which reduces LH pulse frequency, and often FSH to a lesser extent. This reduction in hormone signalling disrupts ovarian function and causes impairments in luteal phase progesterone synthesis. Actions of which manifest as various menstrual disorders, including PMS, oligomenorrhoea, amenorrhoea, annovulation and infertility. [19][20][72][73]
Adverse to intense resistance exercise
Dopamine levels in the dorsal striatum act like an internal “cost evaluator” for movement. When dopamine is low, the brain overestimates the cost of sustaining movement. This is less obvious in non-resistant movements such as walking, and more applicable with intense resistance exercise, where low dopamine candidates have a sharp decline in performance. This indicates low dopamine is connected to a lack of motivation to overcome physical exercise efforts that has been processed as having a high energetic cost. [21][22].
Addictions
-
Alcohol, Nicotine or Drugs
-
Gambling, Shopping or Compulsive sexual behavior
-
Gaming and Social media
When dopamine levels are deficient, the brain’s reward circuits become underactive, leaving ordinary experiences less satisfying. To compensate, individuals may seek out highly stimulating or repetitive activities that temporarily increase dopamine release. This makes them more vulnerable to addictions of various forms, as the drive for external stimulation substitutes for the diminished intrinsic reward signaling. Over time, this can create a cycle where reliance on addictive behaviors deepens, further reinforcing the dopaminergic imbalance. [25][26]
Iron deficient dopamine dysregulation - Restless legs syndrome
RLS is a common neurological condition associated with a strong urge to move the legs, particularly during periods of long sitting and at night. It’s often linked to unpleasant sensations like tingling or crawling, and movement usually provides relief.
Although pharmaceutically dopamine stimulants, such as pramipexole or ropinirole are commonly used to treat RLS, recent research suggests that people with RLS already have a hyperactive dopamine system at night. The issue is more specifically a lack of D2 (inhibitory) receptor stimulation, which is primarily driven by a brain iron deficiency. This is because D2 receptor synthesis relies heavily on iron, and an iron deficiency can lead to a a reduction of D2 synthesis, by up to 70% [23,24]
Therefore in cases of restless legs, iron should be assessed, and dopamine transportation (DAT) should be supported.
Causes
Heavy Metal Toxicity
-
Arsenic
-
Lead
-
Cadmium
-
Mercury
Research has found that exposure to the heavy metals particularly arsenic, lead, and cadmium interfere with the brain’s dopamine system. Studies have shown that when mice were exposed to these metals in their drinking water, dopamine levels in the striatum dropped noticeably. This occurred because the metals reduced the activity of enzymes and transport proteins needed to make, move, and store dopamine. While each metal alone caused a reduction in dopamine, the combined exposure had a much stronger effect, leading to significant dopamine loss. [75]
Further studies have also demonstrated Mercury reduces dopamine uptake in rat brain, interfering with the ability of brain cells to reabsorb dopamine after release, which is essential for normal neurotransmission. [76]
Chronic Marijuana use
Initial exposure to cannabinoids, such as those in marijuana, increases dopamine activity by reducing GABAergic inhibition. This disinhibition allows dopamine neurons to fire more readily, temporarily enhancing dopamine release. However, with chronic use, particularly of THC, the primary psychoactive compound, this effect becomes detrimental.
Long-term THC exposure overstimulates CB1 receptors, leading to dopaminergic downregulation and receptor desensitization. These neuroadaptations disrupt the brain’s dopamine balance,
contributing to low motivation, cognitive impairment, and attention deficits.
Functional neuroimaging studies have also shown reduced dopamine synthesis and signaling in chronic cannabis users, especially in regions such as the ventral striatum and prefrontal cortex. These changes diminish responsiveness to natural rewards, resulting in an increased reliance on cannabis to achieve pleasurable or motivating effects.
Furthermore, THC withdrawal exacerbates dopamine suppression, producing symptoms like depression, irritability, sleep disturbances, and cravings. These effects contribute to the cycle of
continued use and relapse.
Over time, chronic cannabis use impairs the brain’s reward circuitry and diminishes its capacity to recover, potentially leading to long-lasting or persistent dopaminergic dysfunction if use is not moderated or discontinued [29,30].
Chronic Alcohol Consumption
In the early stages of drinking, alcohol increases dopamine release in brain areas like the nucleus accumbens, which creates feelings of pleasure and reward. This dopamine surge helps reinforce alcohol use, making the brain learn to associate alcohol and related cues, like people and places with reward and motivation.
However, with repeated heavy drinking, the brain undergoes significant changes. Tolerance develops, and alcohol’s ability to stimulate dopamine and produce pleasure decreases. Over time, dopamine signaling becomes blunted, meaning the brain releases less dopamine and becomes less responsive to natural rewards.
In parallel, chronic alcohol use leads to a shift in brain control from the prefrontal cortex, involved in conscious decision-making, to habitual circuits in the basal ganglia, where behaviors become automatic, even if the experience of alcohol brings no pleasure itself.
In the long term, chronic alcohol consumption leads to persistent dopaminergic dysfunction, where the brain becomes less sensitive to both alcohol and natural rewards and compulsive drinking patterns form [31].
Cigarettes
When nicotine first enters the body, it stimulates the release of dopamine, particularly within the brain’s mesolimbic reward system, a key pathway involved in pleasure and reinforcement. In addition to triggering dopamine release, nicotine also inhibits the enzymes monoamine oxidase A and B (MAO-A and MAO-B), which normally break down dopamine. This dual action leads to a short-term surge in dopamine levels, contributing to the immediate pleasurable effects of smoking.
However, with repeated exposure, the brain undergoes significant adaptations. One major change is the desensitization and subsequent upregulation of nicotinic acetylcholine receptors (nAChRs), especially the α4β2* subtype, which plays a critical role in regulating dopamine release. Although more of these receptors are produced, they are less functional. As a result, the brain’s ability to release dopamine diminishes sharply, by up to 70%, even when exposed to strong reward-related stimuli [32,33].
This reduction in dopamine activity weakens the brain’s capacity to experience pleasure naturally. Over time, nicotine use becomes necessary not to feel good, but simply to feel normal, reinforcing the cycle of addiction.
Addictive Drugs
Overall all major addictive drugs, such as opiates, amphetamines and cocaine disrupt normal dopamine function. It has been hypothesised that these altercations in dopamine take place to balance the unnatural drug-induced highs, but ultimately it leads to a dopamine-impoverished brain, causing a loss of pleasure from normal activities, and further drug-seeking behaviour [34].
Chronic Stress
Dopamine shows dynamic changes during stress, where initially, stress increases dopamine levels, supporting active coping strategies like escape or resistance. However, in situations that are perceived as uncontrollable or inescapable, dopamine levels drop.
One study demonstrated that people with long-term exposure to psychosocial stress, such as childhood trauma, discrimination, and adult life adversity, show reduced dopamine synthesis in the brain’s striatum, particularly in regions linked to emotion and motivation.
These individuals had a mismatched response to acute stress, where they felt more psychologically threatened but had a weaker physiological response, indicating the impact of low dopamine itself.
In contrast, people with low adversity exposure showed a balanced link between dopamine levels and both emotional and physiological stress responses. The study highlighted that chronic stress can biologically reshape dopamine function and affect the stress response systems [35,36].
Excessive Screen Time
When repeatedly engaging in compulsive dopamine surge behaviors, such as excessive screen time, the mesolimbic dopamine pathway, central to reward processing, becomes desensitized through constant artificial stimulation. This dysregulation is called the "anti-reward state", which means that more screen time is needed just to feel baseline pleasure, while genuine, healthy rewards lose their appeal. This pattern is a hallmark of dopamine dysfunction and behavioral addiction.
These changes are not just behavioral, they reflect deep neurochemical and structural adaptations in the brain’s reward circuitry, often reinforced by chronic stress.
As in example, in the COVID-19 pandemic, this was intensified by Social isolation, disrupted routines, and widespread reliance on digital "rewards", which increased compulsive behaviors worldwide. When people turned to digital content for comfort and stimulation, dopamine systems were "hijacked", reinforcing unhealthy habits that habituate more dopamine dysfunction [37,38].
Social Isolation
Chronic social isolation has been shown to decrease levels of dopamine D2 receptor in the nucleus accumbens (NAcc) and medial prefrontal cortex. This exerted a decrease in activity within the regions of the brain responsible for eliciting reward value to social interactions and also navigating appropriate social responses, encouraging further social avoidance [39].
SIBO
Small Intestinal Bacterial Overgrowth (SIBO) contributes to elevated levels of lipopolysaccharides (LPS), an inflammatory endotoxin produced from Gram-negative bacteria, which naturally produce LPS as part of their outer membrane. It has been demonstrated that LPS induced chronic inflammation causes:
-
Reduces dopamine release in the striatum
-
Decreases D2 receptor binding
-
Leads to dopaminergic neuronal damage and loss
-
Suppresses tyrosine hydroxylase activity, the enzyme crucial for dopamine synthesis [40]
Dysbiosis
Certain gut microbes can produce dopamine precursors like L-DOPA or express enzymes that facilitate dopamine synthesis. However, in circumstances of dysbiosis, when the gut microbiota becomes imbalanced, the abundance of these dopamine-producing bacteria declines, leading to reduced dopamine synthesis.
Experimental studies show that disrupting gut bacteria with antibiotics significantly lowers brain dopamine levels. Conversely, restoring a healthy microbiota via probiotics, fecal transplants, or dietary changes can reverse dopamine deficits and improve cognitive performance.
It is important to note that although gut produced dopamine itself cannot cross the blood–brain barrier, its precursor L-DOPA can, making the gut a key contributor to brain dopamine supply. Dysbiosis impairs both the production and transport of these essential precursors, potentially disrupting brain function and behavior [41].
High Fat Diets
High-fat foods activate the brain’s dopamine-based reward system, driving pleasure and motivation to eat. However, chronic overconsumption of fatty foods can dull this dopamine response by negatively impacting Oleoylethanolamine (OEA), which is part of the gut-brain communication system. The results of which demonstrate reduced reward sensitivity and prompts compensatory overeating [42].
Iron deficiency
In the prefrontal cortex, iron deficiency causes dopamine to be broken down too quickly due to higher activity of an enzyme called MAO. This means dopamine is cleared out faster than normal.
Furthermore, iron deficiency has been shown to reduce Phenylalanine hydroxylase (PAH) by 56%. PAH is a liver enzyme that enables the conversion of phenylalanine to tyrosine, and tyrosine is the amino acid required for dopamine synthesis.
Iron deficiency is also associated with lower production of the dopamine receptor D2, which is a dopamine regulator, preventing over-stimulus and aggravation. Clinical studies have demonstrated alleviating iron deficiency is effective for reducing restless leg syndrome as well as symptoms of ADHD, with a note that there is a 3.8 x greater risk of developing ADHD with iron deficiency [43,44,45,46,47].
Tyrosine deficiency
Tyrosine is used by the enzyme tyrosine hydroxylase, which is considered one of the most important enzymes for dopamine, due to its role in converting Tyrosine into L-DOPA, with L-DOPA beign the direct precursor to dopamine.
Studies have demonstrated that tyrosine supplementation can boost dopamine, but only when tyrosine is deficient. Adding additional tyrosine will not improve dopamine production [48,49].
B6 Deficiency
Vitamin B6 (B6) plays a crucial role in dopamine synthesis, acting as a cofactor for the enzyme dopa-decarboxylase. This enzyme converts the amino acid L-dopa into dopamine. B6 deficiency therefore can disrupt dopamine production [50].
References
[1] https://academic.oup.com/jcem/article-abstract/82/11/3864/2866142
[2] https://www.mdpi.com/2079-7737/10/10/983
[3] https://pmc.ncbi.nlm.nih.gov/articles/PMC8234057/
[4] https://www.ncbi.nlm.nih.gov/books/NBK538242
[5] https://australianprescriber.tg.org.au/articles/dopamine-mechanisms-of-action.html
[6].https://www.sciencedirect.com/science/article/abs/pii/S0028390896001001?via%3Dihub
[7] https://www.ncbi.nlm.nih.gov/books/NBK538242/
[8] https://www.mdpi.com/2073-4409/10/4/735
[9].https://www.sciencedirect.com/science/article/pii/S1053811918320925?via%3Dihub
[10] https://go.drugbank.com/drugs/DB00422
[11].https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1492126/full
[12] https://pubmed.ncbi.nlm.nih.gov/14995087/
[13] https://pubmed.ncbi.nlm.nih.gov/9421921/
[14] https://pubmed.ncbi.nlm.nih.gov/18519527/
[15] https://pmc.ncbi.nlm.nih.gov/articles/PMC6333779/
[16] https://pmc.ncbi.nlm.nih.gov/articles/PMC3529349/
[17] https://pmc.ncbi.nlm.nih.gov/articles/PMC5716179/
[18] https://pubmed.ncbi.nlm.nih.gov/9059216/
[19].https://www.sciencedirect.com/science/article/abs/pii/0306453078900057
[20] https://www.ncbi.nlm.nih.gov/books/NBK560698/
[21] https://pmc.ncbi.nlm.nih.gov/articles/PMC4805420/
[22] https://pubmed.ncbi.nlm.nih.gov/
[23] https://www.e-jsm.org/journal/view.php?doi=10.13078/jsm.230030
[24] https://pmc.ncbi.nlm.nih.gov/articles/PMC5862810/
[25].https://www.sciencedirect.com/science/article/abs/pii/S0149763411000789
[26] https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.202101637R
[27] https://pmc.ncbi.nlm.nih.gov/articles/PMC6352317/
[28] https://www.nature.com/articles/tp2014133
[29] https://pmc.ncbi.nlm.nih.gov/articles/PMC3405830/
[30].https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2021.623403/full
[31].https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/neuroscience-brain-addiction-and-recovery
[32] https://pmc.ncbi.nlm.nih.gov/articles/PMC3400796/
[33] https://pmc.ncbi.nlm.nih.gov/articles/PMC2946180/
[34] https://www.hazeldenbettyford.org/research-studies/addiction-research/drug-abuse-brain
[35].https://www.sciencedirect.com/science/article/abs/pii/S0149763411000789
[36] https://pmc.ncbi.nlm.nih.gov/articles/PMC6850765/
[37] https://pmc.ncbi.nlm.nih.gov/articles/PMC10525914/
[38] https://pmc.ncbi.nlm.nih.gov/articles/PMC11804976/
[39] https://pubmed.ncbi.nlm.nih.gov/33894223/
[40].https://www.mdpi.com/2227-9059/10/2/436#B88-biomedicines-10-00436
[41] https://pmc.ncbi.nlm.nih.gov/articles/PMC8234057/
[42] https://pubmed.ncbi.nlm.nih.gov/23950538/
[43] https://pmc.ncbi.nlm.nih.gov/articles/PMC5434142/
[44] https://pmc.ncbi.nlm.nih.gov/articles/PMC3415866/
[45] https://pubmed.ncbi.nlm.nih.gov/3766433/
[46] https://pmc.ncbi.nlm.nih.gov/articles/PMC5914242/
[47] https://pmc.ncbi.nlm.nih.gov/articles/PMC6353229/
[48] https://pubmed.ncbi.nlm.nih.gov/26424423/
[49] https://pmc.ncbi.nlm.nih.gov/articles/PMC6084775/
[50] https://pmc.ncbi.nlm.nih.gov/articles/PMC9787829/
[51] https://pmc.ncbi.nlm.nih.gov/articles/PMC3575938/
[52] https://pmc.ncbi.nlm.nih.gov/articles/PMC3746283/
[53] https://pmc.ncbi.nlm.nih.gov/articles/PMC4564644/
[54] https://pubmed.ncbi.nlm.nih.gov/24682000/
[55].https://researchmgt.monash.edu/ws/portalfiles/portal/251222495/251029958_oa.pdf
[56] https://www.metagenicsinstitute.com.au/tech-data/bacopa-gingko-complex
[57] https://pmc.ncbi.nlm.nih.gov/articles/PMC9382310/
[58].https://www.biomedica.com.au/media/contentmanager/content/Cognition_Technical_Sheet.pdf
[59] https://onlinelibrary.wiley.com/doi/10.1111/jhn.12090
[60].https://www.sciencedirect.com/science/article/pii/S2590259823000328
[61] https://pmc.ncbi.nlm.nih.gov/articles/PMC9228580/
[62] https://pubmed.ncbi.nlm.nih.gov/16949263/
[63] https://pmc.ncbi.nlm.nih.gov/articles/PMC6563911/
[64].https://digitalcommons.wustl.edu/cgi/viewcontent.cgi?article=11257&context=open_access_pubs
[65] https://www.mdpi.com/2227-9059/10/2/436
[66] https://www.mdpi.com/2227-9059/10/2/436
[67] https://pmc.ncbi.nlm.nih.gov/articles/PMC10437823/
[68] https://www.mdpi.com/2227-9059/10/2/436
[69] https://www.mdpi.com/2227-9059/10/2/436
[70] https://pmc.ncbi.nlm.nih.gov/articles/PMC8301978/
[71] https://pmc.ncbi.nlm.nih.gov/articles/PMC8992377/
[72].https://www.endotext.org/wp-content/uploads/pdfs/hyperprolactinemia.pdf
[73].https://link.springer.com/chapter/10.1007/978-981-15-2377-9_16
[74] https://pmc.ncbi.nlm.nih.gov/articles/PMC4038955/
[75] https://www.mdpi.com/1660-4601/18/12/6558
[76].https://www.sciencedirect.com/science/article/abs/pii/0378427485901146
bottom of page